 |
Replication-incompetent GM-CSF-expressing gene-modified allogeneic pancreatic cancer cell lines |
|---|---|
| Trade Name | Gvax Pancreas |
| Orphan Indication | Pancreatic cancer |
| USA Market Approval | USA |
| USA Designation Date | 2010-03-01 00:00:00 |
| Sponsor | Aduro BioTech, Inc.;740 Heinz Avenue;Berkeley, California, 94710 |
